Amgen falls 3% after 2019 outlook falls short

By | January 29, 2019

Shares of Amgen fell 3 percent in extended trading after the company issued weak 2019 guidance, which overshadowed its better-than-expected fourth-quarter earnings, after the market close on Tuesday.

similar news from Pfizer earlier Tuesday, which also posted strong fourth-quarter results but issued weak 2019 guidance.

Shares of Amgen have fallen about 3 percent over the past year.

Health and Science

Read More:  Can i take ambien after doing coke